Keywords: merck, kgaa, operating, profits, up, glucophage, products
Merck KGaA operating profits up 17% as Glucophage products continue to rise
Article | 08 May 2001
Merck KGaA of Germany has announced a 12% rise in sales forfirst-quarter 2001 to 1.78 billion euros ($1.59 billion), while operating profits climbed 17.1% to 212 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
